At this point, we know who pretty much all the main players are in Doctor Strange, save for a few minor details — although Mads Mikkelsen’s casting was finally confirmed today, all Marvel will let on is that he’s playing the main villain, and the studio is being similarly coy about Rachel McAdams’ role. While many have speculated that the actress is playing Night Nurse, new details on her part in Doctor Strange suggest that’s not entirely accurate, or perhaps not even accurate at all.
Production has officially begun on Marvel’s Doctor Strange, with director Scott Derrickson at the helm and Benedict Cumberbatch as the Sorcerer Supreme in what promises to be a truly unique and, well, strange offering from the MCU. Marvel has formally announced the start of production and confirmed the central cast, including former Hannibal star Mads Mikkelsen, who had previously been in talks for a role.
To be fair, every film with Jeff Bridges is a magical journey, but perhaps none more enchanting than The Little Prince. The official trailer for the long-developing animated film based on Antoine de Saint-Exupéry’s acclaimed children’s novella has landed, promising a lovely, sweet and sometimes funny adventure, with exceptionally beautiful animation.
Over the summer, Daredevil Season 1 showrunner Steven DeKnight revealed that Rosario Dawson’s character on the series wasn’t allowed to go by the name Night Nurse because Marvel executives had plans for the character in a feature film — that film, as many speculated, is likely Doctor Strange, as Night Nurse has a history with the Sorcerer Supreme. And as it turns out, not only may that speculation have been quite correct, but this might be who Rachel McAdams is playing in the upcoming film.
Spotlight is a story about the way things used to be done; a model of journalism in which a reporter might publish one article a year rather than one article a day (or, God help us, an hour). It follows the “Spotlight” unit of The Boston Globe, a four-person team of reporters who investigate big stories for as long as they need. In 2001, Martin Baron (Liev Schreiber) became the new editor of the Globe, and assigned the Spotlight writers the case of a Catholic priest accused of molesting numerous children. But rather than simply cover that one story, the Spotlight staff dug deeper into the Catholic Church’s history of hiding such crimes by moving priests from one place to another. Their work exposed systemic abuse stretching back decades and ultimately won a Pulitzer Prize… but wasn’t published until 2002.
It looks like Dr. Strange is going to have an old friend over for dinner. (Creepy slurping noise.)
It’s reasonably safe to presume that Nicholas Sparks’ theater pull has waned somewhat in the years following The Notebook, so where does one in need of a new frontier go? TV! Yes, The Notebook is coming to the small screen, on The CW of course, and already tissue stock is rising.
The critical derision of True Detective Season 2 came to a head last night with the untimely “Omega Station” finale, but did Nic Pizzolatto’s once-revered drama redeem itself, as HBO promised? Here’s how every major character ended the Vinci-set season, for those dying of heart blue-balls.
One thing is for certain about director Tom McCarthy — he’s been very diverse, which makes him a bit unpredictable. His most recent film was the laughably, inconceivably awful The Cobbler, starring Adam Sandler. But prior to that he made acclaimed films like The Station Agent and Win Win. With that little Adam Sandler hiccup behind us now, we’re free to look forward to Spotlight, a new drama featuring an excellent ensemble cast and some very serious subject matter. Best of all: no magic shoes.
A few weeks ago, we heard that Rachel McAdams was in talks with Marvel for a leading role in Doctor Strange opposite Benedict Cumberbatch. Since then, all’s been quiet on the Sorcerer Supreme front, with no official confirmation or other casting news. But today brings a small update, in the form of an interview with McAdams, who confirms that she is in talks with Marvel, though it’s still a bit early.